Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
The Medical Journal of Australia
|
October 19, 2004
The direct thrombin inhibitor melagatran/ximelagatran
Timothy A Brighton
The Medical Journal of Australia
|
April 9, 2009
The direct factor Xa inhibitor rivaroxaban
Abhishek K Verma, Timothy A Brighton
Methods in Molecular Biology (Clifton, N.J.)
|
May 19, 2023
Serotonin Release Assay: Functional Assay for Heparin- and Vaccine-Induced (Immune) Thrombotic Thrombocytopenia
Mayuko Kondo, Dea Donikian, Timothy A Brighton
Hematology (Amsterdam, Netherlands)
|
June 7, 2008
Platelet function testing in uraemic patients
Shir-Jing Ho, Rosalie Gemmell, Timothy A Brighton
Circulation
|
August 27, 2014
Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration
John Simes, Cecilia Becattini, Giancarlo Agnelli, et al.
American Journal of Obstetrics and Gynecology
|
September 19, 2002
Platelet activation in the hypertensive disorders of pregnancy
Françoise H Harlow, Mark A Brown, Timothy A Brighton, et al.
JAMA Internal Medicine
|
April 16, 2014
Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin
Bruce L Davidson, Sara Verheijen, Anthonie W A Lensing, et al.
Thrombosis and Haemostasis
|
January 12, 2012
Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT: results of a large Australian study
Marie-Christine Morel-Kopp, Chee Wee Tan, Timothy A Brighton, et al.
Blood
|
August 29, 2015
Paris-Trousseau thrombocytopenia is phenocopied by the autosomal recessive inheritance of a DNA-binding domain mutation in FLI1
William S Stevenson, David J Rabbolini, Lucinda Beutler, et al.
The New England Journal of Medicine
|
November 6, 2012
Low-dose aspirin for preventing recurrent venous thromboembolism
Timothy A Brighton, John W Eikelboom, Kristy Mann, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
The Medical Journal of Australia
|
October 19, 2004
The direct thrombin inhibitor melagatran/ximelagatran
Timothy A Brighton
The Medical Journal of Australia
|
April 9, 2009
The direct factor Xa inhibitor rivaroxaban
Abhishek K Verma, Timothy A Brighton
Methods in Molecular Biology (Clifton, N.J.)
|
May 19, 2023
Serotonin Release Assay: Functional Assay for Heparin- and Vaccine-Induced (Immune) Thrombotic Thrombocytopenia
Mayuko Kondo, Dea Donikian, Timothy A Brighton
Hematology (Amsterdam, Netherlands)
|
June 7, 2008
Platelet function testing in uraemic patients
Shir-Jing Ho, Rosalie Gemmell, Timothy A Brighton
Circulation
|
August 27, 2014
Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration
John Simes, Cecilia Becattini, Giancarlo Agnelli, et al.
American Journal of Obstetrics and Gynecology
|
September 19, 2002
Platelet activation in the hypertensive disorders of pregnancy
Françoise H Harlow, Mark A Brown, Timothy A Brighton, et al.
JAMA Internal Medicine
|
April 16, 2014
Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin
Bruce L Davidson, Sara Verheijen, Anthonie W A Lensing, et al.
Thrombosis and Haemostasis
|
January 12, 2012
Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT: results of a large Australian study
Marie-Christine Morel-Kopp, Chee Wee Tan, Timothy A Brighton, et al.
Blood
|
August 29, 2015
Paris-Trousseau thrombocytopenia is phenocopied by the autosomal recessive inheritance of a DNA-binding domain mutation in FLI1
William S Stevenson, David J Rabbolini, Lucinda Beutler, et al.
The New England Journal of Medicine
|
November 6, 2012
Low-dose aspirin for preventing recurrent venous thromboembolism
Timothy A Brighton, John W Eikelboom, Kristy Mann, et al.
Page
of 3